通过电子健康的正念认知疗法对成人焦虑和抑郁的有效性：一项荟萃分析

IF 3.7 2区医学 Q1 PSYCHIATRY

General hospital psychiatry Pub Date : 2025-07-24 DOI:10.1016/j.genhosppsych.2025.07.017

Shizhen Wang , Mengru Wu , Jixiang Wei , Wangjie Xia , Zhen Luo , Li Tian

{"title":"通过电子健康的正念认知疗法对成人焦虑和抑郁的有效性：一项荟萃分析","authors":"Shizhen Wang , Mengru Wu , Jixiang Wei , Wangjie Xia , Zhen Luo , Li Tian","doi":"10.1016/j.genhosppsych.2025.07.017","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Anxiety and depression are highly prevalent mental health disorders, imposing significant burdens on individuals and healthcare systems. Mindfulness-based cognitive therapy (MBCT) has demonstrated effectiveness in reducing these symptoms. Electronic health MBCT (eMBCT) offers a scalable alternative, but its efficacy in alleviating anxiety and depression in adults remains unclear.</div></div><div><h3>Objectives</h3><div>To examine the treatment efficacy of eMBCT for adult anxiety and depression and identify potential moderators associated with better treatment outcomes.</div></div><div><h3>Methods</h3><div>A systematic search was conducted across PubMed, PsycINFO, Web of Science, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials from inception to February 24, 2024. RCTs comparing eMBCT with usual care, waitlist controls, or active interventions in adults with anxiety or depression were included. Two independent reviewers conducted study selection, data extraction, and risk-of-bias assessment using the Cochrane Risk of Bias Tool. Standardized mean differences (SMDs) with 95 % confidence intervals (CIs) were calculated using Review Manager 5.3 and Stata 16.0 to estimate pooled effect sizes.</div></div><div><h3>Results</h3><div>Twelve RCTs (<em>n</em> = 2588) were included. eMBCT significantly reduced anxiety (SMD = −0.33, 95 % CI [−0.52, −0.15], <em>P</em> < 0.001) and depression (SMD = −0.34, 95 % CI [−0.50, −0.17], P < 0.001), with both effects representing a small effect size. Subgroup analysis showed significant short- and long-term effects, but no medium-term benefits. Greater baseline symptom severity was associated with larger improvements.</div></div><div><h3>Conclusions</h3><div>eMBCT effectively alleviates anxiety and depression, with sustained benefits. Future research should enhance its medium-term and long-term effectiveness of eMBCT and explore relevant intervention features that offer patients more flexible and personalized care.</div><div><em>Registration number</em>: CRD42024544712 (PROSPERO).</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"96 ","pages":"Pages 211-222"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of mindfulness-based cognitive therapy via e-health on anxiety and depression in adults: A meta-analysis\",\"authors\":\"Shizhen Wang , Mengru Wu , Jixiang Wei , Wangjie Xia , Zhen Luo , Li Tian\",\"doi\":\"10.1016/j.genhosppsych.2025.07.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Anxiety and depression are highly prevalent mental health disorders, imposing significant burdens on individuals and healthcare systems. Mindfulness-based cognitive therapy (MBCT) has demonstrated effectiveness in reducing these symptoms. Electronic health MBCT (eMBCT) offers a scalable alternative, but its efficacy in alleviating anxiety and depression in adults remains unclear.</div></div><div><h3>Objectives</h3><div>To examine the treatment efficacy of eMBCT for adult anxiety and depression and identify potential moderators associated with better treatment outcomes.</div></div><div><h3>Methods</h3><div>A systematic search was conducted across PubMed, PsycINFO, Web of Science, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials from inception to February 24, 2024. RCTs comparing eMBCT with usual care, waitlist controls, or active interventions in adults with anxiety or depression were included. Two independent reviewers conducted study selection, data extraction, and risk-of-bias assessment using the Cochrane Risk of Bias Tool. Standardized mean differences (SMDs) with 95 % confidence intervals (CIs) were calculated using Review Manager 5.3 and Stata 16.0 to estimate pooled effect sizes.</div></div><div><h3>Results</h3><div>Twelve RCTs (<em>n</em> = 2588) were included. eMBCT significantly reduced anxiety (SMD = −0.33, 95 % CI [−0.52, −0.15], <em>P</em> < 0.001) and depression (SMD = −0.34, 95 % CI [−0.50, −0.17], P < 0.001), with both effects representing a small effect size. Subgroup analysis showed significant short- and long-term effects, but no medium-term benefits. Greater baseline symptom severity was associated with larger improvements.</div></div><div><h3>Conclusions</h3><div>eMBCT effectively alleviates anxiety and depression, with sustained benefits. Future research should enhance its medium-term and long-term effectiveness of eMBCT and explore relevant intervention features that offer patients more flexible and personalized care.</div><div><em>Registration number</em>: CRD42024544712 (PROSPERO).</div></div>\",\"PeriodicalId\":12517,\"journal\":{\"name\":\"General hospital psychiatry\",\"volume\":\"96 \",\"pages\":\"Pages 211-222\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General hospital psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0163834325001537\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General hospital psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163834325001537","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

摘要

焦虑和抑郁是非常普遍的精神健康障碍，给个人和医疗保健系统带来了巨大的负担。正念认知疗法（MBCT）在减轻这些症状方面已经证明是有效的。电子健康MBCT （eMBCT）提供了一种可扩展的替代方案，但其在缓解成人焦虑和抑郁方面的功效尚不清楚。目的探讨eMBCT对成人焦虑和抑郁的治疗效果，并确定与更好治疗结果相关的潜在调节因子。方法系统检索PubMed、PsycINFO、Web of Science、Embase、CINAHL和Cochrane Central Register of Controlled Trials自成立至2024年2月24日的文献。包括比较eMBCT与常规护理、候补对照或积极干预的成人焦虑或抑郁的随机对照试验。两名独立审稿人使用Cochrane偏倚风险工具进行研究选择、数据提取和偏倚风险评估。使用Review Manager 5.3和Stata 16.0计算95%置信区间（ci）的标准化平均差异（SMDs），以估计合并效应大小。结果共纳入12项rct （n = 2588）。eMBCT显著降低焦虑(SMD = - 0.33, 95% CI [- 0.52, - 0.15], P <；0.001)和抑郁(SMD =−0.34,95%可信区间(−0.50−0.17),P & lt;0.001)，两种效应都代表较小的效应量。亚组分析显示短期和长期效果显著，但没有中期效益。基线症状严重程度越高，改善程度越高。结论sembct可有效缓解焦虑和抑郁，且疗效持续。未来的研究应加强eMBCT的中期和长期有效性，探索相关干预特征，为患者提供更加灵活和个性化的护理。注册号：CRD42024544712 （PROSPERO）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Effectiveness of mindfulness-based cognitive therapy via e-health on anxiety and depression in adults: A meta-analysis

Background

Anxiety and depression are highly prevalent mental health disorders, imposing significant burdens on individuals and healthcare systems. Mindfulness-based cognitive therapy (MBCT) has demonstrated effectiveness in reducing these symptoms. Electronic health MBCT (eMBCT) offers a scalable alternative, but its efficacy in alleviating anxiety and depression in adults remains unclear.

Objectives

To examine the treatment efficacy of eMBCT for adult anxiety and depression and identify potential moderators associated with better treatment outcomes.

Methods

A systematic search was conducted across PubMed, PsycINFO, Web of Science, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials from inception to February 24, 2024. RCTs comparing eMBCT with usual care, waitlist controls, or active interventions in adults with anxiety or depression were included. Two independent reviewers conducted study selection, data extraction, and risk-of-bias assessment using the Cochrane Risk of Bias Tool. Standardized mean differences (SMDs) with 95 % confidence intervals (CIs) were calculated using Review Manager 5.3 and Stata 16.0 to estimate pooled effect sizes.

Results

Twelve RCTs (n = 2588) were included. eMBCT significantly reduced anxiety (SMD = −0.33, 95 % CI [−0.52, −0.15], P < 0.001) and depression (SMD = −0.34, 95 % CI [−0.50, −0.17], P < 0.001), with both effects representing a small effect size. Subgroup analysis showed significant short- and long-term effects, but no medium-term benefits. Greater baseline symptom severity was associated with larger improvements.

Conclusions

eMBCT effectively alleviates anxiety and depression, with sustained benefits. Future research should enhance its medium-term and long-term effectiveness of eMBCT and explore relevant intervention features that offer patients more flexible and personalized care.

Registration number: CRD42024544712 (PROSPERO).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

General hospital psychiatry 医学-精神病学

CiteScore

9.60

自引率

2.90%

发文量

125

审稿时长

20 days

期刊介绍： General Hospital Psychiatry explores the many linkages among psychiatry, medicine, and primary care. In emphasizing a biopsychosocial approach to illness and health, the journal provides a forum for professionals with clinical, academic, and research interests in psychiatry''s role in the mainstream of medicine.